Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results Feb 26, 2026 07:01AM
TD Cowen on Viridian Therapeutic (VRDN): 'VRDN is a Top Pick' Jan 6, 2026 03:14PM
TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026' Dec 19, 2025 09:06AM
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results Feb 27, 2025 07:00AM
TD Cowen Starts Viridian Therapeutic (VRDN) at Buy Nov 25, 2024 05:32AM


Feb 28, 2023 08:00AM Viridian Therapeutics to Participate in Cowen’s 43rd Annual Health Care Conference
Feb 22, 2021 08:00AM Viridian Therapeutics to Present at Three Upcoming Investor Conferences